Pathophysiology of non-eosinophilic severe asthma

R. Djukanovic (Southampton, United Kingdom)

Source: International Congress 2017 – Pathophysiology and emerging therapies for severe asthma
Session: Pathophysiology and emerging therapies for severe asthma
Session type: Session
Number: 256
Disease area: Airway diseases

Slide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
R. Djukanovic (Southampton, United Kingdom). Pathophysiology of non-eosinophilic severe asthma. International Congress 2017 – Pathophysiology and emerging therapies for severe asthma

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Pathophysiology of severe non-allergic asthma
Source: International Congress 2019 – Pathophysiology and clinical insights into severe non-allergic asthma
Year: 2019


Pathophysiology of severe asthma phenotypes
Source: International Congress 2014 – PG05 Severe asthma – highlights from the ERS/ATS workshop
Year: 2014




Severe asthma
Source: ISSN=ISSN 1810-6838, ISBN=, page=128
Year: 2006

Severe asthma
Source: International Congress 2014 – ERS/CTS China Day: advances in asthma and COPD
Year: 2014



Severe asthma
Source: ERS Lung Science Conference 2016
Year: 2016


Severe asthma
Source: ERS Course 2019 - Masterclass in airways disease 2019
Year: 2019

Difficult-to-treat and severe asthma
Source: Breathe 2014; 10: 91-94
Year: 2014

Early-onset allergic severe asthma
Source: International Congress 2015 – Severe asthma phenotyping
Year: 2015



Treatment of bronchial asthma and wheezing disorders: chronic
Source: ERS Skills Course 2016
Year: 2016

Treatment of bronchial asthma and wheezing disorders: acute
Source: ERS Skills Course 2016
Year: 2016

Pathophysiology and triggers of acute severe asthma
Source: Annual Congress 2003 - Acute asthma in adults - across the primary/secondary care interface
Year: 2003

Effects of omalizumab on markers of eosinophilic inflammation in patients with severe allergic asthma
Source: Annual Congress 2011 - Biomarkers and exacerbations of asthma and COPD
Year: 2011


Distribution of biomarkers in severe asthma and severe uncontrolled asthma
Source: Virtual Congress 2021 – Pearls in asthma and respiratory burden research
Year: 2021



Severe therapy-resistant asthma
Source: International Congress 2016 – PG8 Paediatric asthma
Year: 2016



Management of difficult-to-treat severe asthma
Source: Eur Respir Mon 2011; 51: 282-296
Year: 2011


Immunotherapy in severe asthma
Source: ERS webinar 2021: Immunotherapy in severe asthma
Year: 2021


Bronchiectasis and aspergillus-associated diseases in severe asthma
Source: International Congress 2019 – Clinical aspects of airway diseases
Year: 2019